96 related articles for article (PubMed ID: 11128072)
1. Emergence of new influenza A viruses which carry an escape mutation of the HLA-B27-restricted CTL epitope of NP in Japan.
Kashiwagi T; Hamada N; Iwahashi J; Hara K; Ueda T; Noguchi H; Toyoda T
Microbiol Immunol; 2000; 44(10):867-70. PubMed ID: 11128072
[TBL] [Abstract][Full Text] [Related]
2. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
Voeten JT; Bestebroer TM; Nieuwkoop NJ; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2000 Aug; 74(15):6800-7. PubMed ID: 10888619
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.
Berkhoff EG; Boon AC; Nieuwkoop NJ; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Virol; 2004 May; 78(10):5216-22. PubMed ID: 15113903
[TBL] [Abstract][Full Text] [Related]
4. Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
Bodewes R; Geelhoed-Mieras MM; Nieuwkoop NJ; Hanson JA; David CS; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Virus Res; 2011 Jan; 155(1):123-30. PubMed ID: 20863862
[TBL] [Abstract][Full Text] [Related]
5. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.
Berkhoff EGM; Geelhoed-Mieras MM; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
J Gen Virol; 2007 Feb; 88(Pt 2):530-535. PubMed ID: 17251571
[TBL] [Abstract][Full Text] [Related]
7. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
Berkhoff EG; de Wit E; Geelhoed-Mieras MM; Boon AC; Symons J; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2005 Sep; 79(17):11239-46. PubMed ID: 16103176
[TBL] [Abstract][Full Text] [Related]
8. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Virol; 2002 Mar; 76(5):2567-72. PubMed ID: 11836437
[TBL] [Abstract][Full Text] [Related]
9. Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations.
Rimmelzwaan GF; Berkhoff EG; Nieuwkoop NJ; Fouchier RA; Osterhaus AD
J Virol; 2004 Aug; 78(16):8946-9. PubMed ID: 15280506
[TBL] [Abstract][Full Text] [Related]
10. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.
Fomsgaard A; Nielsen HV; Kirkby N; Bryder K; Corbet S; Nielsen C; Hinkula J; Buus S
Vaccine; 1999 Nov; 18(7-8):681-91. PubMed ID: 10547428
[TBL] [Abstract][Full Text] [Related]
11. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses.
Bowness P; Moss PA; Rowland-Jones S; Bell JI; McMichael AJ
Eur J Immunol; 1993 Jul; 23(7):1417-21. PubMed ID: 8391985
[TBL] [Abstract][Full Text] [Related]
12. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
13. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
Price GE; Ou R; Jiang H; Huang L; Moskophidis D
J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
[TBL] [Abstract][Full Text] [Related]
14. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
Huet S; Nixon DF; Rothbard JB; Townsend A; Ellis SA; McMichael AJ
Int Immunol; 1990; 2(4):311-6. PubMed ID: 2126195
[TBL] [Abstract][Full Text] [Related]
15. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
Berkhoff EG; Geelhoed-Mieras MM; Verschuren EJ; van Baalen CA; Gruters RA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Clin Exp Immunol; 2007 May; 148(2):296-306. PubMed ID: 17326762
[TBL] [Abstract][Full Text] [Related]
16. A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1.
Ammaranond P; Zaunders J; Satchell C; van Bockel D; Cooper DA; Kelleher AD
AIDS Res Hum Retroviruses; 2005 May; 21(5):395-7. PubMed ID: 15929701
[TBL] [Abstract][Full Text] [Related]
17. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
Boon AC; de Mutsert G; van Baarle D; Smith DJ; Lapedes AS; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Immunol; 2004 Feb; 172(4):2453-60. PubMed ID: 14764717
[TBL] [Abstract][Full Text] [Related]
18. A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro.
Kvist S; Hamann U
Nature; 1990 Nov; 348(6300):446-8. PubMed ID: 2247148
[TBL] [Abstract][Full Text] [Related]
19. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
Cheuk E; Chamberlain JW
Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
[TBL] [Abstract][Full Text] [Related]
20. Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
Rimmelzwaan GF; Kreijtz JH; Bodewes R; Fouchier RA; Osterhaus AD
Vaccine; 2009 Oct; 27(45):6363-5. PubMed ID: 19840674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
